top of page

Biotech CEO Sisterhood: Fresh off of a successful IPO, Avalyn Pharma CEO Lyn Baranowski describes the company's inhaled medicines platform, and shares her secrets to success as a leader

Jul 23

1 min read

Interviewed by Sisterhood editorial board member Erika Smith, Lyn Baranowski highlights the company's $345 million IPO, which enables it to further develop its inhaled medicines. She describes why they believe this delivery method provides a more direct and efficient way to treat fibrotic lung conditions like IPF.

https://vimeo.com/1208483917/236d902581?share=copy&fl=sv&fe=ci

Recent Posts

See All

Biotech CEO Sisterhood: Biotech company chair, director, and former CEO Paula Soteropoulos discusses learnings from her career and announces a new book she and her daughter wrote about women's health

Biotech CEO Sisterhood: Former BIO CEO Rachel King describes her career and shares advice on what makes a successful biotech CEO

Biotech CEO Sisterhood: Katherine Stueland describes joining GeneDx as a first time CEO during a turbulent time and reshaping it into a leader in genetic testing for rare disease diagnosis

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

Mispro is an AAALAC-accredited contract vivarium organization (CVO) offering a network of full-service vivarium rental lab facilities for preclinical in vivo rodent studies. Along with access to state-of-the-art lab spaces, Mispro supports its clients with comprehensive laboratory animal research services, including husbandry, veterinary, technical, and regulatory compliance oversight. With locations in all major U.S. biotech hubs, Mispro is committed to helping biosciences companies of all sizes and therapeutic indications achieve their research goals.

Learn more